FDA WARNING_LETTER - AF Import & Wholesale Co - April 30, 2026

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to AF Import & Wholesale Co. following an inspection of their Houston, Texas, facility conducted on April 29 and 30, 2026. This inspection, which followed up on similar violations noted in 2019, confirmed that the company has failed to comply with federal seafood safety regulations established under the Code of Federal Regulations (21 CFR Part 123) and the Federal Food, Drug, and Cosmetic Act. The core violations involve the company"s failure to implement mandatory Hazard Analysis and Critical Control Point (HACCP) procedures for imported seafood. Specifically, the firm lacks written verification procedures, product specifications, and documented "affirmative steps" to ensure that international suppliers are processing fish under safety standards equivalent to those required in the United States. These are repeat offenses, as the company failed to provide evidence that their imported fishery products were processed under sanitary conditions, rendering the products legally adulterated and potentially injurious to health. To address these issues, the FDA requires AF Import & Wholesale Co. to submit a written response within 15 working days. This response must include documentation of corrective actions, such as updated HACCP records and evidence of supplier verification. The FDA warned that failure to rectify these violations promptly could result in serious regulatory consequences, including the seizure of products, legal injunctions, or the refusal of imported shipments at the border.